Retinal microglia: just bystander or target for therapy?

M Karlstetter, R Scholz, M Rutar, WT Wong… - Progress in retinal and …, 2015 - Elsevier
Resident microglial cells can be regarded as the immunological watchdogs of the brain and
the retina. They are active sensors of their neuronal microenvironment and rapidly respond …

[HTML][HTML] Neuroprotective strategies for retinal disease

MT Pardue, RS Allen - Progress in retinal and eye research, 2018 - Elsevier
Diseases that affect the eye, including photoreceptor degeneration, diabetic retinopathy, and
glaucoma, affect 11.8 million people in the US, resulting in vision loss and blindness. Loss of …

Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma

GR Howell, DG Macalinao, GL Sousa… - The Journal of …, 2011 - Am Soc Clin Investig
Glaucoma is one of the most common neurodegenerative diseases. Despite this, the earliest
stages of this complex disease are still unclear. This study was specifically designed to …

Critical pathogenic events underlying progression of neurodegeneration in glaucoma

DJ Calkins - Progress in retinal and eye research, 2012 - Elsevier
Glaucoma is a common optic neuropathy with a complex etiology often linked to sensitivity to
intraocular pressure. Though the precise mechanisms that mediate or transduce this …

The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice

RM Sappington, BJ Carlson, SD Crish… - … & visual science, 2010 - iovs.arvojournals.org
Purpose.: Elevated intraocular pressure (IOP) is an important risk factor for glaucoma.
Animal models often involve techniques for IOP elevation that are surgically invasive. Here …

Differential progression of structural and functional alterations in distinct retinal ganglion cell types in a mouse model of glaucoma

L Della Santina, DM Inman, CB Lupien… - Journal of …, 2013 - Soc Neuroscience
Intraocular pressure (IOP) elevation is a principal risk factor for glaucoma. Using a
microbead injection technique to chronically raise IOP for 15 or 30 d in mice, we identified …

Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy

RW Nickells, GR Howell, I Soto… - Annual review of …, 2012 - annualreviews.org
Glaucoma is a complex neurodegenerative disorder that is expected to affect 80 million
people by the end of this decade. Retinal ganglion cells (RGCs) are the most affected cell …

Animal models of glaucoma

R A. Bouhenni, J Dunmire, A Sewell… - BioMed Research …, 2012 - Wiley Online Library
Glaucoma is a heterogeneous group of disorders that progressively lead to blindness due to
loss of retinal ganglion cells and damage to the optic nerve. It is a leading cause of …

Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma

M Roh, Y Zhang, Y Murakami, A Thanos, SC Lee… - PloS one, 2012 - journals.plos.org
Background Visual loss in glaucoma is associated with pathological changes in retinal
ganglion cell (RGC) axons and a slow decline in the RGC population. Age and elevated …

Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma

GS Zode, MH Kuehn, DY Nishimura… - The Journal of …, 2011 - Am Soc Clin Investig
Mutations in myocilin (MYOC) are the most common genetic cause of primary open angle
glaucoma (POAG), but the mechanisms underlying MYOC-associated glaucoma are not fully …